Protein needs aren’t one-size-fits-all. Here’s how body weight, age and activity level factor into the new dietary guidelines ...
The original version of this story appeared in Quanta Magazine. In 1939, upon arriving late to his statistics course at UC Berkeley, George Dantzig—a first-year graduate student—copied two problems ...
After more than a month of rumors and feverish speculation — including Polymarket wagering on the release date — Google today unveiled Gemini 3, its newest proprietary frontier model family and the ...
BOSTON - Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), a prominent biotechnology company with a market capitalization of $103.89 billion, announced updated 48-week data for its investigational ...
Vertex delivered a split result this morning that left investors parsing mixed signals. The tax technology provider beat on EPS but missed revenue expectations. Shares were down nearly 10% by the ...
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Saffman Taylor viscous fingering is a classic problem in potential flow theory and exponential asymptotics. In this problem an inviscid fluid is injected into a Hele Shaw channel displacing a viscous ...
24-year-old founder and CEO Carina Hong created Axiom Math in March 2025 and has recruited a team of ten employees, most of whom are from Meta, to build a math-focused AI model. Last fall, Carina Hong ...
With the business potentially at an important milestone, we thought we'd take a closer look at Vertex, Inc.'s (NASDAQ:VERX) future prospects. Vertex, Inc., together with its subsidiaries, provides ...
The heritage British brand has been revived by a chairman whose impressive career before watchmaking includes a three-year stint with Elon Musk. You can find the Vertex Watch Company tucked among the ...
Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators said they didn’t see a path forward for broad use of its pill in treating a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback